Setting up for treatment success: Podcast on management of patients receiving VEGFR-TKI treatment for select solid tumours
Managing patients both pre- and during VEGFR-TKI treatment is an important consideration. Members of GI Nurses CONNECT and GU Nurses CONNECT give their views as to how nurses can play a key role in setting patients up for treatment success. In this podcast, Veerle Lamotte and Paola Belardi discuss the use of VEGFR-TKIs in the treatment of patients with hepatocellular cancer (HCC), differentiated thyroid cancer (DTC) and advanced renal cell carcinoma (aRCC).
Simply click on the podcast to listen here:
Nurse management of AEs in patients receiving VEGFR-TKIs
By Veerle Lamotte, Antwerp University Hospital, Belgium and Paola Belardi, San Donato Hospital, Italy
In this educational podcast, Veerle Lamotte (Belgium) and Paola Belardi (Italy) share their successful experience of managing patients treated with VEGFR-TKIs for select solid tumours.
The short 15-minute discussion captures and provides you with their useful insight on;
1. The safety profile of VEGFR-TKIs alone or in combination with PD-1 inhibitors in hepatocellular cancer (HCC), differentiated thyroid cancer (DTC) & advanced renal cell carcinoma (RCC) and how to recognise side effects & understand appropriate management
2. How to best manage patients both prior to & during treatment to ensure optimal treatment success, including prehabilitation of patients prior to treatment & management of side effects on treatment
Veerle and Paola have many years nursing experience and present views not only from the perspective of the nurse, but also with relevance across geographies.
This is the first collaboration between GI Nurses CONNECT and GU Nurses CONNECT on an educational programme offering a valuable resource that is not limited to one tumour type.
Please respond on a scale of 1 to 5 (5=strongly agree).